Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Aidigong Maternal & Child Health ( (HK:0286) ) just unveiled an announcement.
Aidigong Maternal & Child Health Limited has announced the composition of its board of directors, confirming Huang Wenhua as chairman and chief executive officer, alongside executive director Li Runping and independent non-executive directors Wang Bin and Ma Siu Kit. The company also detailed the membership of its three key board committees, with Wang Bin chairing the audit committee, Ma Siu Kit chairing the nomination committee, and both Ma and Li serving on the remuneration committee, signaling a defined governance structure that may strengthen oversight, independence, and corporate governance practices for stakeholders.
More about Aidigong Maternal & Child Health
Aidigong Maternal & Child Health Limited is a Bermuda-incorporated company listed in Hong Kong (stock code: 286) that focuses on maternal and child health services. The company operates in the healthcare sector, providing specialized care and related services to mothers and infants, targeting the growing market for postnatal and family health solutions in Greater China.
Technical Sentiment Signal: Sell
Current Market Cap: HK$251.6M
Find detailed analytics on 0286 stock on TipRanks’ Stock Analysis page.